A Review of Recent Advances in the Treatment of Elderly and Poor Performance NSCLC

Cancers
Juliet A CarmichaelMary O'Brien

Abstract

Until recently, chemotherapy has remained the mainstay of treatment for the majority of patients with advanced non-small cell lung cancer (NSCLC). Excellent responses have been observed with immune-checkpoint inhibitors, and targeted treatments for those tumours with actionable mutations, resulting in a paradigm shift in the treatment approach for these patients. Elderly patients and those with poor performance status (PS), such as Eastern Cooperative Oncology Group (ECOG) 2, have historically been excluded from clinical trials due to poor outcomes. There is therefore a lack of data to define the optimal treatment strategy for these patients. Due to improved tolerability of novel therapies, inclusion of these patients in clinical trials has increased, and sub-group analyses have identified many treatments demonstrating potential activity. Here, we summarise key recent advances in the treatment of NSCLC, specifically evaluating their efficacy and tolerability in these patient cohorts.

References

Jan 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C RuckdeschelS Vogl
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FrasciM De Lena
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaPaul A Bunn
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Román Pérez-SolerPhilip Bonomi
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rogerio C LilenbaumMark R Green
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jan 18, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M JackmanPasi A Jänne
Feb 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Corey LangerUNKNOWN Eastern Cooperative Oncology Group
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bret WackerPablo J Cagnoni
Jan 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kentaro InamuraYuichi Ishikawa
May 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul Wheatley-PriceFrances A Shepherd
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueUNKNOWN North East Japan Gefitinib Study Group
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Dec 17, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Benjamin SolomonD Ross Camidge
Dec 16, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yoon Hee ChoiIm Il Na
Feb 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alice T Shaw, Benjamin Solomon
Dec 14, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yuh-Min ChenJacqueline Whang-Peng
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Oct 6, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tsuyoshi UenoTetsuya Mitsudomi
May 7, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Alessandro MorabitoFrancesco Perrone
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jun 19, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mauro ZukinRogerio C Lilenbaum
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Sep 10, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Larissa A PikorWan L Lam
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yuankai ShiPan-Chyr Yang

❮ Previous
Next ❯

Citations

Jun 18, 2020·Japanese Journal of Clinical Oncology·Yuichiro OheAkihiko Gemma
Dec 7, 2018·F1000Research·Emily J GuerardNoelle K LoConte
Dec 18, 2020·Cancer Cell International·Rong-Hang HuShao-Qiang Wang
Jul 28, 2021·Advances in Medical Sciences·Damian MojsakRobert Marek Mróz

❮ Previous
Next ❯

Software Mentioned

IPASS
OPTIMAL
SATURN
IFUM
EURTAC
TAILOR

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Chunxia SuMary O'Brien
© 2022 Meta ULC. All rights reserved